ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,408.90
0.36%
S&P ASX All Technology
3,893.00
0.20%
Brent Oil
77.625
0.00%
US Dollar vs AUD
1.58353
0.00%
Bitcoin
104,473.19
-0.25%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Genincode Plc (GENI) Share Price

Genincode Plc

Genincode Plc (GENI)

Genius Metals Inc
Genius Sports Limited
Genius Metals Inc
4.80
-1.00
(-17.24%)
Closed 27 January 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.80
Bid
4.50
Offer
5.00
Volume
2,905,117
4.75 Day's Range 6.125
3.20 52 Week Range 10.125
Market Cap
8.494M
Previous Close
5.80
Open
5.75
Last Trade
350000
@
4.929
(O)
Last Trade Time
Financial Volume
155,572p
VWAP
5.3551
Average Volume (3m)
409,475
Shares Outstanding
176,960,000
Dividend Yield
-
PE Ratio
-1.20
Earnings Per Share (EPS)
-0.04
Revenue
2.16M
Net Profit
-7.02M

About Genincode Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.genincode.com
Headquarters
Manchester, Gbr
Founded
-
Genincode Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GENI. The last closing price for Genincode was 5.80p. Over the last year, Genincode shares have traded in a share price range of 3.20p to 10.125p.

Genincode currently has 176,960,000 shares in issue. The market capitalisation of Genincode is £10.26 million. Genincode has a price to earnings ratio (PE ratio) of -1.20.

Ask ADVFN Intelligence (AI)

GENI Latest News

More News

GENinCode shares rally on test inclusion in clinical lab fee schedule

GENinCode PLC on Thursday saw its share price more than double as it reported key developments relating to its Cardio ...

23 January 2025
Alliance News

GENinCode PLC CARDIO inCode Lab Fee Update & Catalonia Launch

GENinCode PLC 23 January 2025   23 January 2025     GENinCode Plc ("GENinCode" or the "Company")   CARDIO inCode® inclusion in the US CMS 2025 Clinical Lab Fee Schedule and launch in the...

23 January 2025
RNS Regulatory News

GENinCode PLC Partnership with Genesupport SA for the ROCA® Test

GENinCode PLC 10 December 2024   GENinCode Plc ("GENinCode" or the "Company")   GENinCode partners with Genesupport SA for the ROCA® Test in Switzerland Ovarian cancer surveillance using the...

10 December 2024
RNS Regulatory News

GENinCode PLC CARDIO inCode® publication & Trading Update

GENinCode PLC 05 December 2024   5 December 2024     GENinCode Plc ("GENinCode" or the "Company")   CARDIO inCode® publication in International Journal of Cardiology Cardiovascular Risk and...

05 December 2024
RNS Regulatory News

EARNINGS: Origin Enterprises profit falls; GENinCode loss narrows

The following is a round-up of earnings for London-listed companies, issued on Wednesday and Tuesday and not separate ...

26 September 2024
Alliance News

GENinCode PLC Half-year Report

GENinCode PLC 25 September 2024     25 September 2024 GENinCode Plc ("GENinCode", the "Company" or the "Group")   Interim report First US commercial sales for LIPID inCode® and CARDIO inCode®...

25 September 2024
RNS Regulatory News

GENinCode partners with medical centres for cardiovascular screening

GENinCode PLC on Friday announced its collaboration with The Family Heart Foundation, the University of Texas Southwe ...

20 September 2024
Alliance News

GENinCode PLC Collaboration with The Family Heart Foundation

GENinCode PLC 20 September 2024   GENinCode Plc ("GENinCode" or the "Company")   DISCOVER FH collaboration with Family Heart Foundation®, UT Southwestern, and Partners LIPID inCode®, tests...

20 September 2024
RNS Regulatory News

GENinCode PLC Notice of Results

GENinCode PLC 09 September 2024   9 September 2024 GENinCode Plc ("GENinCode" or the "Company")   Notice of results Analyst and investor briefing   Oxford, UK. GENinCode Plc (AIM: GENI), the...

09 September 2024
RNS Regulatory News

GENinCode PLC CARDIO inCode-Score presentation

GENinCode PLC 28 August 2024   GENinCode Plc ("GENinCode" or the "Company")   CARDIO inCode-Score® presentation on polygenic risk of Coronary Heart Disease at 2024 European Society of...

28 August 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.5547.69230769233.258.6253.242858425.76429102DE
4126.31578947373.88.6253.211602965.69903537DE
120.6515.66265060244.158.6253.24094755.57671016DE
26-0.9-15.78947368425.78.6253.22373035.65562034DE
52-0.1-2.040816326534.910.1253.22523336.13135317DE
156-28.2-85.454545454533333.21514659.62142691DE
260-43.7-90.103092783548.548.53.214369212.49478737DE

GENI - Frequently Asked Questions (FAQ)

What is the current Genincode share price?
The current share price of Genincode is 4.80p
How many Genincode shares are in issue?
Genincode has 176,960,000 shares in issue
What is the market cap of Genincode?
The market capitalisation of Genincode is GBP 10.26M
What is the 1 year trading range for Genincode share price?
Genincode has traded in the range of 3.20p to 10.125p during the past year
What is the PE ratio of Genincode?
The price to earnings ratio of Genincode is -1.2
What is the cash to sales ratio of Genincode?
The cash to sales ratio of Genincode is 3.89
What is the reporting currency for Genincode?
Genincode reports financial results in GBP
What is the latest annual turnover for Genincode?
The latest annual turnover of Genincode is GBP 2.16M
What is the latest annual profit for Genincode?
The latest annual profit of Genincode is GBP -7.02M
What is the registered address of Genincode?
The registered address for Genincode is ONE, ST. PETERS SQUARE, MANCHESTER, M2 3DE
What is the Genincode website address?
The website address for Genincode is www.genincode.com
Which industry sector does Genincode operate in?
Genincode operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PPSProton Motor Power Systems Plc
0.325p
(85.71%)
4.07M
CTAICatenai Plc
0.255p
(34.21%)
79.48M
MILAMila Resources Plc
0.23p
(31.43%)
27.89M
SNGSynairgen Plc
2.34p
(26.66%)
6.36M
GILDGuild Esports Plc
0.05p
(25.00%)
34.84M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
EXREngage Xr Holdings Plc
1.55p
(-20.92%)
12.64M
RNWHRenew Holdings Plc
720.00p
(-20.79%)
2.45M
UKRUkrproduct Group Limited
2.00p
(-20.00%)
1.25k
PREMPremier African Minerals Limited
0.0245p
(-2.00%)
2.6B
TRPTower Resources Plc
0.0295p
(7.27%)
1.07B
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
RRRRed Rock Resources Plc
0.0525p
(-4.55%)
198.76M

Discussion

View Full Feed
EZmoney- EZmoney- 5 minutes ago
T53 guess who's back !!!
Truthsocial Truthsocial 6 minutes ago
FO DF
RDGL
ChannelTrader ChannelTrader 6 minutes ago
That would solve the problem.
Golden Cross Golden Cross 6 minutes ago
💲 000 Stocks Can make You Rich!
Golden Cross Golden Cross 8 minutes ago
💲 000 Stocks Can make You Rich!
arizona1 arizona1 8 minutes ago
Trump Supporters Are Begging Him For Their Jobs Back

https://substackcdn.com/image/fetch/w_2250,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe1724342-3fad-42ff-b838-435b57d6caad_1125x720.jpeg

http
janice shell janice shell 10 minutes ago
Yes, of course. Uqora. The story of the founder, Jenna Ryan, is probably familiar to a very large number of women. Symptoms can be sort of vague, and they can change, and they can be hard to describe to a doctor. I think some kind of regime like the one they suggest makes sense. They evidently have
StayHumble StayHumble 10 minutes ago
perForbes Insiders CE0💹KevinLamb💹+💹Bryan Cranston wow $UBQU

https://x.com/CorporateUbqu/status/1802724359762506049
https://x.com/I_Outcomes/status/1812870363094626701

".......believe it... i'm insider too ......"
https://cdn.vo
UBQU
igotthemojo igotthemojo 10 minutes ago
about what i expected...i think its time for your nap little boy...
PLUG
Gmenfan Gmenfan 11 minutes ago
How much are second hand parachutes? And I'm being kind here.....
igotthemojo igotthemojo 12 minutes ago
i told you the last time you made that comment about yarn that it was stupid...and then you repeated the same nonsense...

you were DEAD WRONG then and you are DEAD WRONG now...

"And yes, we know, "this time is different"."

FINALLY you have stated somethin
KBLB
ilovetech ilovetech 13 minutes ago
If I were the CEO of NWBO, I would SERIOUSLY consider the block chain dividend strategy, which Danish posted about on X. That is unless LP has decided to go with a merger, for example, with a company like Revimmune to register under a new CUSP number, where both strategies have successfully squeeze
NWBO
Airfred Airfred 13 minutes ago
Love the idea I’ll sign

Long time reader first time writing
FNMA
Pnypnchr Pnypnchr 14 minutes ago
This is ihub, that will never change me.
BLTHD
Investor2014 Investor2014 14 minutes ago
Exactly, a correlation to actual endpoints of the trial must be established.
It also has yet to be shown to be correlated with or causative of clinical outcomes.

From there further trials would be needed, where brain atrophy reduction is confirmed correlated to cognitive and/or
AVXL
MightyX MightyX 15 minutes ago
Your homies allow-you to f-bomb..good show for-the public
TPTW
georgejjl georgejjl 15 minutes ago
Pantheon and Syntagon combined give Anavex the production process control and capacity to produce Blarcamesine for commercialization and worldwide distribution and sales.

https://patheon.com/

https://www.syntegon.com/company

Good luck and GOD bless,
AVXL
PEACHMAN PEACHMAN 15 minutes ago
Plenty of accurate due diligence and news available at IFUS website

https://impactfusionbrands.com/news/

IFUS STRONG
IFUS
StayHumble StayHumble 16 minutes ago
Update!💹FundersWait✅2Ensure $DBMM Still Trades✅idiot💹

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its regis
DBMM GTII HPIL
SHEEPWOLF SHEEPWOLF 16 minutes ago
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR
SHEEPWOLF SHEEPWOLF 17 minutes ago
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR

Your Recent History

LSE
GENI
Genincode
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads